Cannabis Companies Reduce 2022 Growth Expectations After Challenging Q4

This data-driven, fact-based tracker will continually update based on new financial filings so that readers can stay up to date.

When we launched this resource in May 2019, companies with quarterly revenue in excess of US$2.5 million qualified.

We note that often operating income can include one-time items like stock compensation, inventory write-downs or public listing expenses, and we recommend that readers understand how these non-cash items can impact quarterly financials.

Trulieve, Columbia Care, Ayr Wellness, Jushi and TILT Holdings all provided full year guidance or Q4 2022 guidance that was below the prior expectations of the analysts, extending on the trend from earlier in the month.

According to Sentieo, Verano’s Q4 revenue is expected to increase 183% from a year ago to $210 million, up slightly from Q3.

For each of them, M&A has helped boost the growth compared to a year ago.

For our readers who are interested in staying on top of scheduled earnings calls in the sector, we have have created and continually update the Cannabis Investor Earnings Conference Call Calendar.

…Read the full story